Article

A case of primary biliary cirrhosis associated with pernicious anemia: a case report.

Department of Internal Medicine and Infectious diseases, University Hospital F Hached,4000, Sousse, Tunisia.
Cases Journal 01/2010; 3:11. DOI:10.1186/1757-1626-3-11
Source: PubMed

ABSTRACT Primary biliary cirrhosis is often associated with autoimmune diseases. However, its association with pernicious anemia has rarely been reported.We report a case of a 68-year-old woman who presented jaundice and pruritus. Mildly elevated serum levels of alkaline phosphatase and gamma-glutamyl transpeptidase were detected. The titer of anti-mitochondrial M(2 )anti-body was elevated. Histology of liver biopsy showed features of primary biliary cirrhosis. In addition, aregenerative macrocytic anemia was found in the full blood count. The diagnosis of pernicious anemia was established by megaloblastosis in bone marrow, atrophic gastritis without Helicobacter pylori, low level of vitamin B(12 )and good response to treatment regimen of vitamin B(12). The association of primary biliary cirrhosis and pernicious anemia is unlikely to be casual and may be explained by autoimmune mechanism commonly shared by the diseases.

0 0
 · 
1 Bookmark
 · 
113 Views
  • Article: Primary biliary cirrhosis.
    [show abstract] [hide abstract]
    ABSTRACT: Primary biliary cirrhosis is a chronic cholestatic liver disease of adults. This disorder is characterised histologically by chronic non-suppurative destruction of interlobular bile ducts leading to advanced fibrosis, cirrhosis, and liver failure. The precise aetiopathogenesis of primary biliary cirrhosis remains unknown, although dysregulation of the immune system and genetic susceptibility both seem to be important. Affected patients are typically middle-aged women with abnormal serum concentrations of alkaline phosphatase. Presence of antimitochondrial antibody in serum is almost diagnostic of the disorder. Identification of primary biliary cirrhosis is important, because effective treatment with ursodeoxycholic acid has been shown to halt disease progression and improve survival without need for liver transplantation. However, therapeutic options for disease-related complications-including fatigue and metabolic bone disease-remain unavailable. Mathematical models have been developed that accurately predict the natural history of primary biliary cirrhosis in individuals. Despite advances in understanding of the disease, it remains one of the major indications for liver transplantation worldwide.
    The Lancet 08/2003; 362(9377):53-61. · 38.28 Impact Factor
  • Article: A female with asymptomatic primary biliary cirrhosis associated with pernicious anemia.
    [show abstract] [hide abstract]
    ABSTRACT: We experienced a female case with asymptomatic primary biliary cirrhosis that was associated with pernicious anemia after 16 years from the onset. She was 52 years old when she first visited a clinic in 1981 for liver dysfunction treatment. Antimitochondrial antibody was negative and antipyruvate dehydrogenase complex antibody was positive in a low titer in its immunoglobulin (Ig)M type. Histological examination of her liver revealed a presence of definite chronic non-suppurative destructive cholangitis with numerous epithelioid cell granuloma. She had been given 600 mg of the oral daily dose of ursodeoxycholic acid since 1992. Macrocytic anemia incidiously appeared in September 1999. An immunological examination detected negative antiparietal cell antibodies and positive anti-intrinsic factor antibodies. Her bone marrow smear showed numerous megaloblasts and serum vitamin B12 in her blood was low at 99 pg/mL. Severe reversed atrophic-type gastritis (type A gastritis) was demonstrated by the use of dye-endoscopy with Congo red. Her macrocytic anemia dramatically improved after intramuscular administration of vitamin B12. In conclusion, attention should be given to the association of pernicious anemia during the follow up of primary biliary cirrhosis.
    Journal of Gastroenterology and Hepatology 01/2002; 16(12):1420-4. · 2.87 Impact Factor
  • Article: Anti-parietal cell antibody in autoimmune liver diseases is associated with gastric mucosal atrophy and intestinal metaplasia.
    Advances in experimental medicine and biology 02/1995; 371B:1087-9. · 1.09 Impact Factor

Full-text (2 Sources)

View
5 Downloads
Available from
26 Mar 2013

Keywords

68-year-old woman
 
alkaline phosphatase
 
anti-mitochondrial M(2 )anti-body
 
aregenerative macrocytic anemia
 
autoimmune mechanism
 
bone marrow
 
full blood count
 
gamma-glutamyl transpeptidase
 
Helicobacter pylori
 
Histology
 
low level
 
Mildly
 
pernicious anemia
 
primary biliary cirrhosis
 
treatment regimen
 
vitamin B(12 )and good response